top of page
Search
Writer's pictureBiomedical Bonding

BMB attends the AtiO conference 2024 in Berlin

BMB, represented by its Founder, Prof. Michael Malkoch, attended the ATiO 2024 meeting in Berlin to engage with top-tier surgeons and established medtech companies in the orthopedic field. As one of fourteen carefully selected startups focusing on future solutions in Orthobiologics, BMB showcased its unique platform, Bonevolent™ - injectable implants personalized by surgeons for patients' fractures. Bonevolent™ is centered around blue-light curable composites with the aim of advancing orthopedic care through tailored solutions, starkly differentiating itself from the current standard of metal implants.



Kommentare


bottom of page